Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-28 Purchase |
2023-10-02 4:23 pm |
ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer |
86,258 | $3.7093 | $319,954 | 89,227 (Direct) |
View |
| 2021-12-31 Sale |
2022-01-04 4:06 pm |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
120,000 | $0 | $0 | 216,422 (Direct) |
View |
| 2021-12-20 Purchase |
2021-12-20 4:20 pm |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
25,000 | $0.389 | $9,725 | 336,422 (Direct) |
View |
| 2021-06-10 Purchase |
2021-06-10 7:29 pm |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
10,000 | $1.025 | $10,250 | 311,422 (Direct) |
View |
| 2020-11-17 Purchase |
2020-11-18 5:14 pm |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
9,090 | $2.2 | $19,998 | 143,542 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 4:30 pm |
N/A 2035-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer |
152,300 | $0 | 152,300 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:38 pm |
N/A 2034-01-01 |
ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:00 pm |
N/A 2033-01-02 |
ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer |
700,000 | $0 | 700,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-23 4:08 pm |
N/A 2032-02-18 |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
300,000 | $0 | 816,422 (Direct) |
View |
| 2021-05-20 Tax Withholding |
2021-05-21 4:26 pm |
N/A N/A |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
42,120 | $0.86 | 301,422 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-03 7:57 pm |
N/A 2031-02-03 |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
350,000 | $0 | 493,542 (Direct) |
View |
| 2020-06-05 Tax Withholding |
2020-06-08 5:41 pm |
N/A N/A |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
31,590 | $3.31 | 134,452 (Direct) |
View |
| 2020-05-22 Tax Withholding |
2020-05-26 5:16 pm |
N/A N/A |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
39,487 | $4.99 | 166,042 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 12:30 pm |
N/A N/A |
Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary |
7,802 | $5.24 | 205,529 (Direct) |
View |